Media coverage

Fierce Biotech – Charles River’s capture compound mass spectrometry enables Enyo Pharma’s target identification

https://www.fiercebiotech.com/cro/charles-river-s-capture-compound-mass-spectrometry-enables-enyo-pharma-s-target-identification

Insight Success – ENYO Pharma: Leveraging viruses to develop first-in-class drug candidates in many indications

http://www.insightssuccess.com/enyo-pharma-leveraging-viruses-to-develop-first-in-class-drug-candidates-in-many-indications

Bref Rhône Alpes – Novadiscovery et ENYO Pharma ensemble contre l’hépatite B

https://www.brefeco.com/actualite/energie/novadiscovery-et-enyo-pharma-ensemble-contre-lhepatite-b

EASME – ENYO helps your body give the cold shoulder to viruses

https://ec.europa.eu/easme/en/news/enyo-helps-your-body-give-cold-shoulder-viruses

Labiotech.eu – French Hepatitis Cure is on Track with Positive Phase I Results

https://labiotech.eu/enyo-hepatitis-b-eyp001-phase-i/